Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 47 of 100
Months After Trump Scolded Pfizer About Raising Drug Prices, It’s Raising Prices on 41 Drugs, Report Says
By
Kevin Kelleher
November 16, 2018
FDA Recalls Yet Another Blood Pressure Medication, Losartan, Due to Cancer Concerns
By
Brittany Shoot
November 13, 2018
Health
Explaining Amarin’s Fishy Stock Slide
By
Sy Mukherjee
November 12, 2018
Another Popular Blood Pressure Drug Has Been Recalled by the FDA Over Potential Cancer Risk
By
Brittany Shoot
November 1, 2018
Retail
CVS Is Testing Out Prime-Like Memberships as Amazon Jumps Into Prescription Drugs
By
Lucas Laursen
October 31, 2018
Health
A Health Insurer’s Latest Plan to Cut Drug Costs? Pay Patients to Visit Mexico
By
Lucas Laursen
October 31, 2018
Health
The FDA Approved the First Big New Flu Drug in Almost 20 Years—And Is Approaching a Drug Approval Record
By
Sy Mukherjee
October 24, 2018
Health
These Are the Health Care Companies Poised for Explosive Growth
By
Sy Mukherjee
October 18, 2018
Health
Novartis Is Paying $2.1 Billion for Endocyte, a Company That’s Developing a New Prostate Cancer Treatment
By
David Meyer
October 18, 2018
Trump Signs 2 Drug Pricing Bills, HHS Secretary Promises ‘More to Come’
By
Brittany Shoot
October 11, 2018
Health
Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO
By
Sy Mukherjee
October 11, 2018
Kroger Is Piloting Grocery Pickup in Walgreens Stores in Retail’s Latest Plan to Fight Amazon
By
Kevin Kelleher
October 2, 2018
Health
Exclusive: This Startup Wants to Score You Cheap Prescription Drugs. Now It’s Offering Home Delivery
By
Sy Mukherjee
October 2, 2018
Pfizer CEO Ian Read to Step Aside Next Year for Albert Bourla to Take the Reins
By
Don Reisinger
October 1, 2018
Health
A Superstar Team of Hospitals Is Sick of High Drug Prices—And Launching a Nonprofit Drug Company to Fight Them
By
Sy Mukherjee
September 6, 2018
Most Popular
Commentary
Ray Dalio: I've studied 500 years of history and fear we're entering the most dangerous phase of the 'Big Cycle'
By
Ray Dalio
Success
When Jamie Dimon was fired from Citigroup, his daughters asked: 'Will we be homeless? Can I still go to college? Can I...
By
Eleanor Pringle
Middle East
Trump's AI czar calls for U.S. to 'get out' of war and warns Iran has a 'dead man's switch' that could render Gulf...
By
Jason Ma